DHB-mVenus Citations (4)
Originally described in: The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit.Spencer SL, Cappell SD, Tsai FC, Overton KW, Wang CL, Meyer T Cell. 2013 Oct 10;155(2):369-83. doi: 10.1016/j.cell.2013.08.062. Epub 2013 Sep 26. PubMed Journal
Articles Citing DHB-mVenus
| Articles |
|---|
| Genome-wide CRISPR screen identifies noncanonical NF-kappaB signaling as a regulator of density-dependent proliferation. Fomicheva M, Macara IG. Elife. 2020 Nov 13;9. pii: 63603. doi: 10.7554/eLife.63603. PubMed |
| Indisulam synergizes with palbociclib to induce senescence through inhibition of CDK2 kinase activity. Pogacar Z, Johnson JL, Krenning L, De Conti G, Jochems F, Lieftink C, Velds A, Wardak L, Groot K, Schepers A, Wang L, Song JY, van de Ven M, van Tellingen O, Medema RH, Beijersbergen RL, Bernards R, Leite de Oliveira R. PLoS One. 2022 Sep 6;17(9):e0273182. doi: 10.1371/journal.pone.0273182. eCollection 2022. PubMed |
CDT1 inhibits CMG helicase in early S phase to separate origin licensing from DNA synthesis.
Ratnayeke N, Baris Y, Chung M, Yeeles JTP, Meyer T.
Mol Cell. 2023 Jan 5;83(1):26-42.e13. doi: 10.1016/j.molcel.2022.12.004.
PubMed
Associated Plasmids |
Analysis and modeling of cancer drug responses using cell cycle phase-specific rate effects.
Gross SM, Mohammadi F, Sanchez-Aguila C, Zhan PJ, Liby TA, Dane MA, Meyer AS, Heiser LM.
Nat Commun. 2023 Jun 10;14(1):3450. doi: 10.1038/s41467-023-39122-z.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.